Stockscreener 앱 받기
55.88
2.17%
-1.24
시간 외 거래:
56.00
0.12
+0.21%
전일 마감가:
$57.12
열려 있는:
$57.975
하루 거래량:
3.88M
Relative Volume:
0.77
시가총액:
$9.94B
수익:
$803.32M
순이익/손실:
$-709.10M
주가수익비율:
-7.1638
EPS:
-7.8003
순현금흐름:
$-212.68M
1주 성능:
-0.16%
1개월 성능:
-15.68%
6개월 성능:
-8.20%
1년 성능:
-18.26%
1일 변동 폭
$55.72
$57.98
1주일 범위
$49.88
$57.98
52주 변동 폭
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
명칭
Tempus Ai Inc
전화
800-976-5448
주소
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
55.88 | 10.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
186.99 | 30.35B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
BTSG
Brightspring Health Services Inc
|
39.34 | 7.17B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.35 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.24 | 5.08B | 550.17M | 201.35M | 232.07M | 1.00 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-10-20 | 개시 | Canaccord Genuity | Buy |
| 2025-09-02 | 개시 | H.C. Wainwright | Buy |
| 2025-04-21 | 개시 | BTIG Research | Buy |
| 2025-02-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 재개 | TD Cowen | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-12-09 | 개시 | Guggenheim | Buy |
| 2024-11-11 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-12 | 개시 | Piper Sandler | Neutral |
| 2024-07-09 | 개시 | BofA Securities | Buy |
| 2024-07-09 | 개시 | JP Morgan | Overweight |
| 2024-07-09 | 개시 | Longbow | Buy |
| 2024-07-09 | 개시 | Loop Capital | Buy |
| 2024-07-09 | 개시 | Morgan Stanley | Overweight |
| 2024-07-09 | 개시 | Needham | Buy |
| 2024-07-09 | 개시 | Stifel | Buy |
| 2024-07-09 | 개시 | TD Cowen | Buy |
| 2024-07-09 | 개시 | William Blair | Outperform |
모두보기
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Jim Cramer on Tempus (TEM): "It's Going to Go Back Down Again" - Finviz
Tempus AI Stock (TEM) Opinions on Short Seller Report - Quiver Quantitative
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24 - Caledonian Record
AI in Oncology Research and Long-term Forecasts Report 2026-2040: Siemens Healthineers and GE Healthcare Lead, While NVIDIA, IBM, Tempus, PathAI, and Emerging Specialists Expand Use Cases - Yahoo Finance Singapore
Looking Into Tempus AI Inc's Recent Short Interest - Benzinga
Stock Report: Is Tempus AI Inc stock risky to hold nowJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Artificial Intelligence Stocks Worth WatchingFebruary 8th - MarketBeat
Top Artificial Intelligence Stocks To Keep An Eye OnFebruary 7th - MarketBeat
Artificial Intelligence Stocks To Follow NowFebruary 6th - MarketBeat
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Stock Position in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI Shares Jump After FDA Approves Updated Cardiac Imaging Platform - MSN
Do Tempus AI’s New IPS Results Reframe TEM’s Edge In Precision Oncology Diagnostics? - Yahoo Finance
Best Artificial Intelligence Stocks To ResearchFebruary 5th - MarketBeat
Can Tempus AI’s (TEM) Immune Profile Score Redefine Its Edge In Precision Oncology Data? - simplywall.st
Tempus AI Links Hereditary Cancer Data And Immune Scoring To Growth Prospects - Yahoo Finance
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Globe and Mail
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
Tempus AI, Inc. (TEM): A Bull Case Theory - Finviz
Insider Sell: David Epstein Sells 370 Shares of Tempus AI Inc (T - GuruFocus
Tempus AI (NASDAQ:TEM) Director Sells $21,981.70 in Stock - MarketBeat
Promising Artificial Intelligence Stocks To Watch NowFebruary 4th - MarketBeat
RSI Alert: Tempus AI (TEM) Now Oversold - Nasdaq
Tempus AI Stock (TEM) Opinions on Q4 Earnings Beat - Quiver Quantitative
New DNA study could sharpen cancer risk for thousands of patients - stocktitan.net
Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
AI in Oncology Market to Reach US$ 22.85 Billion by 2033, Growing - openPR.com
Best Artificial Intelligence Stocks To Watch TodayFebruary 2nd - MarketBeat
Tempus AI, Inc. (TEM) Investor Outlook: Navigating a 46.97% Upside Amidst High Growth and Strategic Collaborations - DirectorsTalk Interviews
What's Going On With Tempus AI Stock Monday?Tempus AI (NASDAQ:TEM) - Benzinga
RNA in cancer gene tests found 1 in 25 positives otherwise missed - stocktitan.net
Artificial Intelligence Stocks To Keep An Eye OnFebruary 1st - MarketBeat
Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones - Finviz
Mirae Asset Global Investments Co. Ltd. Increases Stake in Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks To Follow TodayJanuary 31st - MarketBeat
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 166,250 Shares of Stock - MarketBeat
Promising Artificial Intelligence Stocks To Watch TodayJanuary 30th - MarketBeat
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals - MSN
Tempus AI Inc (TEM) Trading Down 4.09% on Jan 30 - GuruFocus
Esoteric Testing Research Report 2026 - GlobeNewswire Inc.
Is Tempus AI Inc. stock a good dividend stockWeekly Trade Review & Community Verified Swing Trade Signals - mfd.ru
Tempus AI's COO Ryan Fukushima sells shares worth $2.27 million - MSN
Top Artificial Intelligence Stocks To Watch TodayJanuary 3rd - MarketBeat
TEM vs. DOCS: Which Medical-Tech Stock Looks Promising Amid AI Boom? - Finviz
21,000 Shares in Tempus AI, Inc. $TEM Purchased by Hussman Strategic Advisors Inc. - MarketBeat
Should Tempus AI’s (TEM) New Immunotherapy Prediction Data Shift How Investors View Its Moat? - simplywall.st
Tempus AI (TEM) Valuation Check After New Immune Profile Score Data And High Profile Investor Interest - Yahoo Finance
Tempus AI study shows improved cancer immunotherapy prediction By Investing.com - Investing.com Australia
Tempus AI Expands Cancer Tools As Shares Trade Below Analyst Estimates - Yahoo Finance
Tempus AI’s Clinical Breakthrough: A Potential Catalyst for Growth - AD HOC NEWS
Tempus AI IPS Study Points To Wider Immunotherapy Use And Investor Interest - simplywall.st
Is It Time To Reassess Tempus AI (TEM) After Its Strong 1 Year Share Price Run? - Yahoo Finance UK
Tempus Ai Inc (TEM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.06%
0.13%
자본화:
|
볼륨(24시간):